No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
175 |
4. Check minimum number of eventsNone |
175 |
5. Include endpointsNone |
175 |
6. Filter based on genotype QC (FinnGen only) |
145 |
Control definitions (FinnGen only)
- Control exclude
- E4_GLUCOPANCREAS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E15-E16
- Name in latin
- Coma hypoglychaemicum non diabeticum
Similar endpoints
↥List of similar endpoints to
Nondiabetic hypoglycaemic coma
based on the number of shared cases.
Similar with more cases:
- Other disorders of glucose regulation and pancreatic internal secretion
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1177 | 513 | 627 |
| Only index persons | 618 | 283 | 335 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.01 | 0.02 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 46.88 | 50.02 | 44.06 |
| Only index persons | 34.95 | 33.91 | 35.83 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 145 | 69 | 76 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 25.18 | 25.86 | 24.56 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 146
- Matched controls
- 1460
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A10AA02, ,
ATC
122.1
182.3
105
30
A10AA01, ,
ATC
119.9
177.0
100
26
A10AB01
ATC
insulin (human); parenteral
110.8
174.5
101
29
A10AC01
ATC
insulin (human); parenteral
79.6
161.2
110
54
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
95.5
150.3
85
21
2510B
ICD-9 Finland
Other disorders of pancreatic internal secretion, Hypoglycaemic coma[COMA HYPOGLYCAEMICUM]
+∞
141.7
112
*
H04AA01
ATC
glucagon; nasal, parenteral
78.6
134.2
78
21
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
49.6
124.3
86
41
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
66.0
124.3
75
23
A10AB05
ATC
insulin aspart; parenteral
44.4
121.6
90
51
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
100.0
117.2
63
11
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
74.5
115.2
66
16
A10AB04
ATC
insulin lispro; parenteral
50.7
113.6
74
29
A10AE04
ATC
insulin glargine; parenteral
31.9
104.5
92
74
T89
ICPC
Diabetes insulin dependent
37.6
96.7
69
34
A10AE05
ATC
insulin detemir; parenteral
33.9
86.7
63
32
103
Kela drug reimbursment
Diabetes, insulin-treated
30.5
83.3
123
218
E10
ICD-10 Finland
Type 1 diabetes mellitus
40.2
69.3
45
16
A10AE06
ATC
insulin degludec; parenteral
29.6
69.2
51
26
215
Kela drug reimbursment
Diabetes, non-insulin-treated
16.6
66.7
102
179
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
131.6
37.9
39
*
E15
ICD-10 Finland
Nondiabetic hypoglycaemic coma
+∞
37.1
34
*
SPAT1262
SPAT
Handing over of treatment supplies
8.5
33.9
58
105
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
+∞
33.6
31
*
H3600, E103,
ICD-10 Finland
87.7
31.5
34
5
A10AD01
ATC
insulin (human); parenteral
52.6
28.2
33
8
XCK10
NOMESCO Finland
Photography of fundus of eye
9.7
28.2
38
51
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
44.7
24.1
29
8
H3603, E103,
ICD-10 Finland
99.9
23.5
25
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
142.4
23.3
24
*
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
95.1
22.4
24
*
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
31.1
21.4
28
11
177
Kela drug reimbursment
Insulin glargine 300 U / ml
23.8
20.5
29
15
OAB50, ,
SPAT
7.8
19.7
31
49
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
81.0
19.3
21
*
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
60.8
18.5
21
*
A10AA03, ,
ATC
36.6
17.6
22
7
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
4.6
16.9
55
169
H3601, E103,
ICD-10 Finland
34.7
16.6
21
7
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
43.3
15.8
19
5
H36.00
ICD-10 Finland
Diabetic background retinopathy
32.8
15.7
20
7
H36.01
ICD-10 Finland
Diabetic maculopathy
50.9
15.5
18
*
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
89.3
14.9
16
*
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
40.7
14.8
18
5
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
165.9
14.7
15
*
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
20.8
13.8
20
11
A10AD04
ATC
insulin lispro; parenteral
+∞
13.8
13
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.2
13.3
45
140
H43.1
ICD-10 Finland
Vitreous haemorrhage
35.6
12.9
16
5
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
141.7
12.6
13
*
CKC12
NOMESCO Finland
Photocoagulation of retina
11.2
12.3
23
24
171
Kela drug reimbursment
Degludekinsuliini
70.8
11.8
13
*
E16.19
ICD-10 Finland
Other specified hypoglycaemia
+∞
11.6
11
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
9.0
10.6
22
28
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
+∞
10.5
10
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.4
10.4
48
182
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
12.7
9.9
17
15
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
106.7
9.5
10
*
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
+∞
9.5
9
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
4.9
9.2
22
51
C10AA05
ATC
atorvastatin; oral
2.9
9.2
65
313
A10AB06
ATC
insulin glulisine; parenteral
39.3
9.2
11
*
OAB50
NOMESCO Finland
Delivery of care equipment and instruction on their use
25.9
9.1
12
5
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.5
9.0
24
61
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
15.3
8.9
14
10
BEF00, ,
SPAT
29.5
8.6
11
*
CL2S4, ,
SPAT
13.9
8.6
14
11
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
5.1
8.4
19
42
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
11.8
8.0
14
13
C10AX09
ATC
ezetimibe; oral
3.4
7.9
34
121
C10AA01
ATC
simvastatin; oral
2.8
7.8
57
275
R11
ICD-10 Finland
Nausea and vomiting
4.2
7.7
22
59
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
26.6
7.7
10
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
7.3
7.4
17
26
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
16.8
7.4
11
7
25008
ICD-8 Finland
Diabetes mellitus, Complicatio alia definita
+∞
7.3
7
*
2503B
ICD-9 Finland
Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]
+∞
7.3
7
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
12.9
7.2
12
10
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
10.1
6.9
13
14
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
11.8
6.9
12
11
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.3
6.8
29
102
WZC30
NOMESCO Finland
Teaching
3.1
6.8
34
132
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
23.8
6.8
9
*
V03AE01
ATC
polystyrene sulfonate; oral
23.8
6.8
9
*
C03CA01
ATC
furosemide; systemic
2.7
6.7
46
212
A11CC03
ATC
alfacalcidol; systemic
13.1
6.7
11
9
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
72.9
6.5
7
*
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
72.9
6.5
7
*
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
72.9
6.5
7
*
H3603, E113,
ICD-10 Finland
72.9
6.5
7
*
OAB42, ,
SPAT
3.2
6.4
28
100
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
19.0
6.3
9
5
B05DA
ATC
Isotonic solutions
28.0
6.3
8
*
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
+∞
6.3
6
*
E10.0
ICD-10 Finland
Type 1 diabetes mellitus, With coma
+∞
6.3
6
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
7.8
6.1
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
98
308
7.64
32.98
9.7
4.5
16.40
11.25
mg/mmol
0.36
78
215
22
45
5.58
10.65
7.3
3.9
24.93
24.24
mmol/l
0.35
22
45
67
314
3.10
10.10
2.2
1.4
4.83
1.07
u/ml
0.55
25
79
19
22
9.75
9.64
2.9
2.1
104.82
125.32
ug/min
—
14
10
28
84
3.89
8.44
4.2
2.7
4.45
4.74
kpa
0.25
28
84
20
50
4.48
7.63
7.1
3.8
46.23
51.18
%
0.28
20
50
84
1094
0.45
5.04
5.2
4.5
8.15
5.81
mmol/l
10.14
78
1028
12
22
5.84
4.71
3.4
3.0
1.13
1.52
mmol/l
1.61
12
22
41
210
2.32
4.62
2.2
1.6
465.41
466.66
pmol/l
0.01
32
181
15
38
4.28
4.45
2.4
18.4
1.28
1.68
%
1.35
15
33
17
58
3.19
4.17
2.6
2.4
1.69
1.61
%
0.06
17
58
22
88
2.77
4.11
1.2
1.3
186.44
131.64
u/ml
0.24
11
38
17
59
3.13
4.05
2.5
2.4
0.77
0.63
%
0.83
17
59
17
60
3.07
3.94
4.2
3.4
1.77
1.22
mmol/l
0.53
11
44
12
37
3.44
3.01
3.3
2.6
23.29
24.37
mmol/l
0.47
12
37
28
146
2.14
2.96
7.7
8.0
103.11
104.47
mmol/l
0.63
28
146
73
534
1.73
2.71
20.3
8.8
1.21
1.21
mmol/l
0.49
65
466
70
892
0.59
2.57
3.8
3.4
—
—
—
0
0
10
31
3.39
2.57
1.1
1.1
—
7.60
—
0
5
6
11
5.63
2.57
2.7
2.9
1.19
1.18
mmol/l
—
6
11
6
11
5.63
2.57
2.7
2.9
105.33
107.91
mmol/l
—
6
11
69
503
1.70
2.56
3.2
1.9
1.02
1.42
mmol/l
4.94
62
441
8
25
3.32
2.13
5.8
8.1
—
5390.00
—
0
5
5
10
5.13
2.08
1.2
1.8
10.60
11.00
mmol/l
—
5
10
6
18
3.43
1.76
5.0
4.6
14.23
16.26
%
—
6
18
0
49
0.00
1.72
0.0
1.3
—
—
—
0
0
8
31
2.67
1.68
1.3
2.3
—
—
—
0
0
7
27
2.67
1.53
17.3
6.0
16.71
10.44
pmol/l
—
7
27
100
863
1.50
1.47
6.3
4.1
15.25
14.81
pmol/l
0.83
91
808
9
41
2.27
1.40
2.8
2.7
—
—
—
0
0
0
37
0.00
1.36
0.0
1.5
—
—
—
0
0
20
123
1.73
1.32
8.1
12.7
2.29
1.32
mmol/l
0.30
14
101
19
291
0.60
1.25
2.9
4.3
25.17
23.29
%
0.17
11
124
26
368
0.64
1.22
3.4
4.7
1.43
1.69
ug/l
0.51
26
324
8
38
2.17
1.20
2.5
2.4
—
—
—
0
0
7
31
2.32
1.12
1.6
1.2
—
—
—
0
0
36
268
1.46
1.09
2.8
2.5
—
—
—
0
0
116
1057
1.47
1.08
8.3
4.9
1.97
1.83
mu/l
0.66
109
985
51
414
1.36
0.94
4.2
3.4
31.16
21.30
ng/l
0.98
40
253
6
28
2.19
0.92
1.2
1.1
—
—
—
0
0
0
25
0.00
0.80
0.0
1.5
—
—
—
0
0
0
25
0.00
0.80
0.0
1.6
—
—
—
0
0
0
28
0.00
0.77
0.0
1.1
—
0.22
—
0
5
9
54
1.71
0.76
2.4
1.4
—
—
—
0
0
12
76
1.63
0.74
2.1
1.6
—
—
—
0
0
11
68
1.67
0.74
5.2
2.8
23.71
24.54
mmol/l
0.18
11
68
5
27
1.88
0.69
1.0
1.3
310.40
60.58
pmol/l
—
5
27
7
43
1.66
0.68
1.9
2.1
103.00
98.65
%
—
7
43
39
319
1.30
0.67
4.9
3.1
0.28
0.34
e6/l
0.17
30
230
26
200
1.37
0.67
3.7
2.8
4.71
0.72
e6/l
0.46
15
101
0
23
0.00
0.59
0.0
1.0
—
—
—
0
0
15
107
1.45
0.58
7.6
2.8
0.43
0.21
e6/l
0.44
15
102
6
37
1.65
0.56
2.2
2.5
251.50
184.49
%
—
6
37
15
108
1.43
0.55
2.9
3.3
—
—
—
0
0
9
61
1.51
0.55
2.0
1.6
—
—
—
0
0
16
213
0.72
0.55
2.0
2.2
—
—
—
0
0
6
39
1.56
0.53
3.8
3.6
60.43
48.52
mg/l
—
6
31
6
39
1.56
0.53
3.8
3.6
57.52
25.40
mg/l
—
6
31
58
511
1.22
0.53
4.5
2.8
76.85
74.15
nmol/l
0.31
52
478
113
1186
0.79
0.51
28.9
14.4
29.05
23.02
mg/l
0.78
97
936
82
886
0.83
0.48
6.3
4.0
17.76
9.09
mm/h
2.46
74
841
8
116
0.67
0.48
7.5
8.8
—
—
—
0
0
15
193
0.75
0.42
2.0
2.1
—
—
—
0
0
5
33
1.53
0.41
2.8
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
243.20
—
0
15
0
18
0.00
0.40
0.0
1.1
—
13.28
—
0
8
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
2.8
—
7.66
—
0
18
11
147
0.73
0.39
2.0
1.6
—
—
—
0
0
11
147
0.73
0.39
2.1
1.7
—
—
—
0
0
113
1177
0.82
0.39
9.1
4.7
4.22
4.67
mmol/l
6.52
108
1115
22
182
1.25
0.36
3.9
3.0
2.11
2.33
e6/l
0.05
11
86
113
1173
0.84
0.34
8.9
4.6
1.57
1.40
mmol/l
3.45
108
1107
6
88
0.67
0.34
2.5
2.3
—
—
—
0
0
7
99
0.69
0.32
2.3
2.3
—
—
—
0
0
66
611
1.15
0.31
5.5
3.5
0.00
0.00
estimate
-0.00
18
127
121
1170
1.20
0.31
32.8
16.2
138.50
139.75
mmol/l
6.68
116
1150
7
57
1.24
0.29
17.6
17.7
14.16
15.90
%
—
7
52
50
456
1.15
0.29
2.3
2.1
112.33
95.10
pmol/l
1.14
29
244
23
266
0.84
0.27
4.0
3.8
1.02
1.02
kg/l
0.25
14
181
8
67
1.21
0.27
1.6
1.3
—
—
—
0
0
121
1174
1.18
0.27
34.5
16.2
4.05
3.95
mmol/l
3.42
116
1153
6
81
0.73
0.25
1.5
1.8
46.83
33.88
nmol/l
—
6
81
66
620
1.12
0.24
5.6
3.5
0.23
0.00
estimate
0.47
13
121
5
38
1.33
0.23
2.0
1.8
—
—
—
0
0
37
336
1.14
0.23
6.4
3.7
0.00
0.01
estimate
0.50
14
122
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.6
—
3.32
—
0
13
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
109
1120
0.89
0.19
7.2
4.0
1.15
1.34
mmol/l
2.34
103
1050
67
701
0.92
0.16
10.9
11.0
4.35
4.13
e9/l
0.38
62
623
23
207
1.13
0.16
10.6
4.1
0.80
0.81
mmol/l
0.18
23
202
38
357
1.09
0.13
5.6
2.9
0.13
0.01
estimate
0.43
15
105
10
86
1.17
0.11
1.9
3.5
57.80
67.05
ml/min/173m2
—
5
38
64
618
1.06
0.10
5.6
3.6
62.25
12.40
estimate
0.36
20
131
55
529
1.06
0.10
3.7
2.9
—
—
estimate
—
0
0
113
1111
1.08
0.10
23.5
13.4
84.87
87.89
ml/min/173m2
0.62
113
1039
49
471
1.06
0.09
5.6
3.5
0.00
0.00
estimate
-0.00
16
109
39
372
1.07
0.09
7.9
3.6
2.35
2.36
mmol/l
0.26
39
352
6
73
0.81
0.08
1.0
1.0
—
—
—
0
0
27
256
1.07
0.07
1.6
1.8
0.71
1.16
mg/l
0.83
21
198
20
189
1.07
0.05
2.4
1.9
—
—
—
0
0
22
210
1.06
0.04
1.4
1.3
38.76
7.54
u/ml
—
10
93
16
167
0.95
0.01
1.4
1.5
—
—
—
0
0
26
266
0.97
0.00
1.8
1.6
—
—
—
0
0
23
233
0.98
0.00
1.3
1.3
16.87
26.59
iu/ml
—
6
74
0
7
0.00
0.00
0.0
1.4
—
1.42
—
0
7
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
52.63
—
0
8
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
3.2
—
97.80
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
117.33
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
31.70
—
0
6
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
5.07
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint E4_HYPOCOMA and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_HYPOCOMA | 4.588 [1.64, 12.87] | 0.004 |
| Birth year | 0.987 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 67 out of 143 males with E4_HYPOCOMA died.
Mortality risk
Mortality risk for people of age
years, who have E4_HYPOCOMA.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.841% |
| 5 | No data | 5.63% |
| 10 | No data | 13.552% |
| 15 | No data | 23.531% |
| 20 | No data | 36.266% |
Relationships between endpoints
↥Index endpoint: E4_HYPOCOMA – Nondiabetic hypoglycaemic coma
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data